Skip to main content
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1978 Jun;3:68–72.

Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer.

M V Alvarez, G Cobreros, A Heras, M C Lopez Zumel
PMCID: PMC2149413  PMID: 277260

Abstract

Cis-dichlorodiammineplatinum (II) (cisDDP) has been extensively studied as an antitumour agent; its binding to DNA has been proved but the radiosensitizing action has scarcely been tested. We report here that on TC.SV -40 mammalian cells cisDPP acts as a dose-modifying factor for ionizing radiation. The radiosensitizing action can be induced by two different mechanisms: reaction with non protein-SH groups and inhibition of repair processes. The cisDDP-DNA complex was studied against increasing radiation doses by analytical centrifugation and by spectrophotometrical measurements. The native complex seems to be more radiation resistant than the denatured one.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Connors T. A., Jones M., Ross W. C., Braddock P. D., Khokhar A. R., Tobe M. L. New platinum complexes with anti-tumour activity. Chem Biol Interact. 1972 Nov;5(6):415–424. doi: 10.1016/0009-2797(72)90078-6. [DOI] [PubMed] [Google Scholar]
  2. Harris J. W., Patt H. M. Non-protein sulfhydryl content and cell-cycle dynamics of Ehrlich ascites tumor. Exp Cell Res. 1969 Jul;56(1):134–141. doi: 10.1016/0014-4827(69)90406-6. [DOI] [PubMed] [Google Scholar]
  3. Horácek P., Drobník J. Interaction of cis-dichlorodiammineplatinum (II) with DNA. Biochim Biophys Acta. 1971 Dec 16;254(2):341–347. doi: 10.1016/0005-2787(71)90842-2. [DOI] [PubMed] [Google Scholar]
  4. Howle J. A., Gale G. R. Cis-dichlorodiammineplatinum (II). Persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo. Biochem Pharmacol. 1970 Oct;19(10):2757–2762. doi: 10.1016/0006-2952(70)90102-4. [DOI] [PubMed] [Google Scholar]
  5. Rosenberg B., VanCamp L., Trosko J. E., Mansour V. H. Platinum compounds: a new class of potent antitumour agents. Nature. 1969 Apr 26;222(5191):385–386. doi: 10.1038/222385a0. [DOI] [PubMed] [Google Scholar]
  6. Speer R. J., Ridgway H., Hall L. M., Stewart D. P., Howe K. E., Lieberman D. Z., Newman A. D., Hill J. M. Coordination complexes of platinum as antitumor agents. Cancer Chemother Rep. 1975 May-Jun;59(3):629–641. [PubMed] [Google Scholar]
  7. Zák M., Drobník J. Effect of cis-dichlorodiamine platinum (II) on the post-irradiation lethality in mice after irradiation with X-rays. Strahlentherapie. 1971 Jul;142(1):112–115. [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES